Digestive Diseases and Sciences

, Volume 44, Issue 3, pp 553–559 | Cite as

Reduction in hMSH2 mRNA Levels by Premature Translation Termination (Implications for Mutation Screening in Hereditary Nonpolyposis Colorectal Cancer)

  • Xuede Lin
  • Jai H. Choi
  • Patrick Lynch
  • Lixuan Xi
  • Elsie Wu
  • Marsha L. Frazier


We have used single-strand conformationalpolymorphism (SSCP) and heteroduplex analysis to examineDNA from 50 colorectal carcinoma patients coming fromfamilies meeting the Amsterdam criteria for hereditary nonpolyposis colorectal cancer (HNPCC) orhaving developed colorectal carcinoma at age 45 oryounger. We identified mutations in 12 of thesepatients, with seven of these being novel mutations. Weexamined four of the truncating mutations using in vitrotranscription and translation (IVTT) assays anddetermined that the mutation causing an in-framedeletion of exon 5 could easily be detected by the IVTTassay, but the three mutations resulting in prematuretranslation termination were not detected because thesteady-state levels of the mutant allele transcripts aretoo low. Our findings suggest that some but not all mutant hMSH2 alleles have significantlylower steady-state mRNA levels than the normal allele.Under ideal circumstances, where lymphoblastoid celllines are available for RNA extraction, IVTT may be useful for detecting truncating mutations.However, our data suggest that caution should be takenin using IVTT in routine screening of clinical samplesfor truncating HNPCC mutations, as many mutations may go undetected.



Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, Hamilton SR, Peterson GM, Kinzler KW, Vogelstein B, de la Chapelle A: Clues to the pathogenesis of familial colorectal cancer. Science 260:812-816, 1993Google Scholar
  2. 2.
    Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jendins NA, Garber J, Kane M, Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038, 1993Google Scholar
  3. 3.
    Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M, Guan X-Y, Zhang J, Meltzer PS, Yu J-W, Kao F-T, Chen DJ, Cerosaletti KM, Founier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin J-P, Jarvinen H, Pete rsen GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, de la Chapelle A, Kinzler DW, Vogelstein B: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1225, 1993Google Scholar
  4. 4.
    Papadopoulos N, Nicolaides NC, Wei Y-F, Rube SM, Carter KC, Rosen CA, Haseltine WA, Fleischmann RD, Fraser CM, Watson P, Lynch HT, Peltomaki P, Mecklin J-P, de la Chapelle A, Kinzler KW, Vogelstein B: Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625-1629, 1994Google Scholar
  5. 5.
    Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindbolm A, Tannergard P, Bollag RJ, Godwin AR, Ward DC, Nordenskjold M, Fishel R, Kolodner R, Liskay RM: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature 368:258-261, 1994Google Scholar
  6. 6.
    Palombo F, Gallinari P, Iaccarino I, Letteri T, Hughes M, DArrigo A, Truong O, Hsuan JJ, Jiricny J: GTBP, a 160-kilodalton protein e ssential for mismatch-binding activity in human cells. Science 268:1912-1914, 1995Google Scholar
  7. 7.
    Papadopoulos N, Nicolaides NC, Liu B, Parsons R, Lengauer C, Palomo F, D'Arrigo A, Mardowitz S, Willson JKV, Kinzler KW, Jiricny J, Vogelstain B: Mutations of GTBP in genetically unstable cells. Science 268:1915-1917, 1995Google Scholar
  8. 8.
    Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, Igari T, Koike M, Chiba M, Mori T: Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nature Genet 17:271-272, 1997Google Scholar
  9. 9.
    Liu B, Nicolaide NC, Markowitz S, Willson JKV, Parson RE, Jen J, Papadopolous N, Peltomaki P, de la Chapelle A, Hamilton SR, Kinzler KW, Vogelstein B: Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet 9:48-55, 1995Google Scholar
  10. 10.
    Brow MD, Oldenburg M, Lyamichev V, Heisler L, Grotelueschen J, Lyamichev N, Kozyavkin S, Fors L, Dahlberg J, Smith L, Olive DM. Mutation detection by Cleavaset fragment length polymorphism analysis. Focus 18:2-6, 1996Google Scholar
  11. 11.
    Grompe M: The rapid detection of unknown mutations in nucleic acids. Nature Genet 5:111-117, 1993Google Scholar
  12. 12.
    Luce MC, Marra G, Chauhan DP, Laghi L, CareThe rs JM, Cherian SP, Hawn M, Binnie CG, Kam-Morgan LNW, Cayouette MC, Koi M and Boland CR. In vitro transcription/ translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology 109:1368-1374, 1995Google Scholar
  13. 13.
    Liu B, Parsons RE, Hamilton SR, Petersen GM, Lynch HT, Watson P, Markowitz S, Willson JKV, Green J, de la Chapelle A, Kinzler KW, Vogelstein B: hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds. Cancer Res 54:4590-4594, 1994Google Scholar
  14. 14.
    Xia L, Wei S, Ritacca F, Mitri A, Madlensky L, Berk T, Cohen Z, Gallinger S, and Bapat B: A truncated hMSH2 transcript occurs as a common variant in the population: Implications for genetic diagnosis. cancer Res 56:2289-2292, 1996Google Scholar
  15. 15.
    Vasen HF, Mecklin JP, Meera Khan P, Lynch HT: The international collaborative group on hereditary nonpolyposis colorectal cancer. Dis Colon Rectum 34:424-425, 1991Google Scholar
  16. 16.
    Chomczynski P, Sacchi N: Single-step method of RNA isola-tion by acid guanidium thiocyanate phenol chloroform extractionAnal Biochem 162:156-159, 1987Google Scholar
  17. 17.
    Wijnien J, Vasen H, Khan PM, Menko FH, van der Klift H, van Leeuwen C, van den Broek M, van Leeuwen-Corne lisse I, Nage ngast F, Meijers-Heijboer A, Lindhout D, Griffioen G, Cats A, Kle ibeuker J, Varesco L, Bertario L, Bisgaard ML, Mohr J, Fodde R: Seven new mutations in hMSH2, an HNPCC gene, identi® ed by denaturing gradient gel e lectrophoresis. Am J Hum Genet 56:1060-1066, 1995Google Scholar
  18. 18.
    Jeon HM, Lynch PM, Howard L, Ajani J, Levin B, Frazier ML: Mutation of the hMSH2 gene in two families with hereditary nonpolyposis colorectalcancer. Hum Mutat 7:327-333, 1996Google Scholar
  19. 19.
    Jones DV, Wu E, Manire M, Frazier ML: Cis-acting elements required for expression of the nonspecific cross-re acting antigen gene in colorectal carcinoma. Gastroenterology 112:776-782, 1997Google Scholar
  20. 20.
    Peltomaki P, Vasen HFA, International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer: Mutations predisposing to hereditary nonpolyposis colorectal cancer: Database and results of a collaborative study. Gastroenterology 113:1146-1158, 1997Google Scholar
  21. 21.
    Froggatt NJ, Joyce JA, Davies R, Evans DGR, Ponder BAJ, Barton DE, Maher ER: A frequent hMSH2 mutation in hereditary nonpolyposis colon cancer syndrome. Lancet 345:727, 1995Google Scholar
  22. 22.
    Barker GF, Beemon K: Nonsense codons within The rous sarcoma virus gag genedecre ase the stability of unspliced viral RNA. Mol Cell Biol 11:2760-2768, 1991Google Scholar
  23. 23.
    Losson R, Lacroute F: Interference of nonsense mutations with eukaryotic messenger RNA stability. Proc Natl Acad Sci USA 76:5134-5137, 1979Google Scholar
  24. 24.
    Zhang S, Ruiz-Echevarria MJ, Quan Y, Peltz SW: Identification and characterization of a sequence motif involved in nonsense mediated mRNA decay. Mol Cell Biol 15:2231-2244, 1995Google Scholar
  25. 25.
    Peltz SW, Brown AH, Jacobon A: mRNA destabilization triggered by premature translational termination depends on at least three cis-acting sequence elements and one trans-acting sequence elements and one trans-acting factor. Genes Dev 7:1737-1754, 1993Google Scholar
  26. 26.
    Hagan KW, Ruiz-echevarria MJ, Quan Y, Peltiz SW: Characterization of cis-acting sequences and decay intermediates involved in nonsense mediated mRNA turnover. Mol Cell Biol 15:809-823, 1995Google Scholar
  27. 27.
    Urlaub G, Mitchell PJ, Ciudad CJ, Chasin LA: Nonsense mutations in the dihydrofolate reductase gene affect RNA processing. Mol Cell Biol 9:2868-2880, 1989Google Scholar
  28. 28.
    Maquat LE, Belgrader P: Nonsense but not missense mutations can decrease the abundance of nuclear mRNA for the mouse major urinary protein, while both types of mutations can facilitate exon skipping. Mol Cell Biol 14:6326-6336, 1994Google Scholar
  29. 29.
    Cheng J, Maquat LE: Nonsense codons can reduce the abundance of nuclear mRNA without affecting the abundance of pre-mRNA or the half life of cytoplasmic mRNA. Mol Cell Biol 13:1892-1902, 1993Google Scholar
  30. 30.
    Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting Highlights and Be thesda Guidelines. J Natl Cancer Inst 89:1758-1762, 1997Google Scholar
  31. 31.
    Wijnen J, Khan PM, Vasen H, Menko F, vander Klift H, van den Brock M, van Leeuwen-Cornelisse I, Nagengast F, Meijers-Heijboer EJ, Lindhout D, Griffioen G, Cats A, Kleibeuker J, Varesco L, Bertario L, Bisgaard ML, Mohr J, Kolodner R, Fodde R: Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Gene t 58:300-307, 1996Google Scholar

Copyright information

© Plenum Publishing Corporation 1999

Authors and Affiliations

  • Xuede Lin
  • Jai H. Choi
  • Patrick Lynch
  • Lixuan Xi
  • Elsie Wu
  • Marsha L. Frazier

There are no affiliations available

Personalised recommendations